Pherin Pharmaceuticals

Phone Icon (650) 636-7064

New Therapeutics;

Microdose Delivery


 

Drug Development Expertise for a Better Tomorrow

Pherin Pharmaceuticals is the leader in the development of first-in-class compounds called pherines, administered as a nasal spray in ultra-low dose without the need for systemic exposure. Pherines have excellent safety profile and rapid onset of efficacy demonstrated in clinical trials. We have a diverse product portfolio that increases the probability of commercial success and believe that the therapeutic advantages of our product candidates will result in pherines becoming an important new class of approved pharmaceuticals.

  

ABOUT US

Pherin Pharmaceuticals is a privately held clinical stage drug development company headquartered in Mountain View, California. We focus on the development of proprietary compounds called pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions.

Pherin Pharmaceuticals is led by a highly experienced senior management team. We have assembled a network of external experts to bring our products through all aspects of development successfully. 

THE PHERIN PIPELINE INCLUDES:
Pherin Pipeline

NEWS

March 10, 2019 U.S. FDA Grants VistaGen Therapeutics Fast Track Designation for PH94B for Treatment of Social Anxiety Disorder

Contact us for strategic collaborations and licensing opportunities

Mailing Address
Pherin Pharmaceuticals
P.O. Box 4081
Los Altos, CA 94024-9991

Phone
(650) 636-7064

Share